Art

J-GLOBAL ID：201702240539691683   Reference number：17A1341063

Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata

腹膜播種性平滑筋腫症に対するアロマターゼ阻害剤投与の長期有効性と安全性

Author (6)： Ando Hitomi (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan) ,  Kusunoki Soshi (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan) ,  Ota Tsuyoshi (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan) ,  Sugimori Yayoi (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan) ,  Matsuoka Shozo (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan) ,  Ogishima Daiki (Department of Obstetrics & Gynecology, Juntendo Nerima Hospital, Faculty of Medicine, Juntendo University, Tokyo, Japan)
Material： Journal of Obstetrics and Gynaecology Research  (J Obstet Gynaecol Res)
Volume： 43  Issue： 9  Page： 1489-1492  Publication year： Sep. 2017 
JST Material Number： W1429A  ISSN： 1341-8076  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： panhysterectomy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1341063&from=J-GLOBAL&jstjournalNo=W1429A") }}

Author keywords (4)： aromatase inhibitor ,  estrogen ,  leiomyomatosis peritonealis disseminata ,  letrozole

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Letrozole

Reference (11)：

• Yang R, Xu T, Fu Y, Cui S, Yang S, Cui M. Leiomyomatosis peritonealis disseminata associated with endometriosis: A case report and review of the literature. Oncol Lett 2015; 9: 717-720.
• Yamaguchi T, Imamura Y, Yamamoto T, Fukuda M. Leiomyomatosis peritonealis disseminata with malignant change in a man. Pathol Int 2003; 53: 179-185.
• Vaquero ME, Magrina JF, Leslie KO. Uterine smooth-muscle tumors with unusual growth patterns. J Minim Invasive Gynecol 2009; 16: 263-268.
• Bekkers RL, Willemsen WN, Schijf CP, Massuger LF, Bulten J, Merkus JM. Leiomyomatosis peritonealis disseminata: Does malignant transformation occur? A literature review. Gynecol Oncol 1999; 75: 158-163.
• Clavero PA, Nogales FF, Ruiz-Avila I, Linares J, Concha A. Regression of peritoneal leiomyomatosis after treatment with gonadotropin releasing hormone analogue. Int J Gynecol Cancer 1992; 2: 52-54.

Terms in the title (6)： 腹膜播種 ,  平滑筋腫症 ,  アロマターゼ阻害剤 ,  投与 ,  長期有効性 ,  安全性